Public Company News
Mabwell Announces IND Application Acceptance for CDH17-Targeting ADC 7MW4911 from Both NMPA and FDA
SHANGHAI, Aug. 1, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911, has received Investigational New Drug (IND) application acceptance fromChina's Na...
2025-08-01 22:00
3939
MDJM Signs Design Collaboration Agreement with Kengo Kuma and Associates for Fernie Castle Redevelopment Project to Enhance Cultural Exchange and Long-Term Value Creation
LETHAM, Scotland, Aug. 1, 2025 /PRNewswire/ -- MDJM LTD (Nasdaq: UOKA) (the "Company" or "MDJM"), an integrated global culture-driven asset management company, today announced that its wholly owned subsidiary, MD Local Global Limited, had entered into a design collaboration agreement withKengo Ku...
2025-08-01 20:30
3658
Kazia Therapeutics Announces $2 Million Private Placement at Premium to Market
SYDNEY, Aug. 1, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced that it has entered into a securities purchase agreement with certain established institutional investors for a private placement of equity securities (PIP...
2025-08-01 20:00
5482
Huya Celebrates Success with Inaugural Delta Force Diamond Champions Summer Season Tournament
GUANGZHOU, China, Aug. 1, 2025 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game-related entertainment and services provider, recently successfully concluded its inaugural Delta Force Diamond Champions (DDC) Summer Season, demonstrating Huya's continued commitment t...
2025-08-01 18:45
3063
Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson's Disease
* The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and pharmacokinetics of the investigational drug in 24 healthy subjects. * The results confirmed the favorable safety and tolerability profile of ...
2025-08-01 15:52
2592
Zeekr Group Announces July 2025 Delivery Update
HANGZHOU, China, Aug. 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its delivery results forJuly 2025. In July, Zeekr Group delivered a total of 44,193 vehicl...
2025-08-01 15:30
2604
GenScript Biotech's MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader
PISCATAWAY, N.J., July 31, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a leading global provider of life science research and manufacturing services, today announced that its ESG rating has been upgraded to AA from A by MSCI in recognition of the company's excellence in the area...
2025-08-01 10:02
2436
OSR Holdings Provides Transparency Update on Equity Financing Instruments
BELLEVUE, Wash., July 31, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovation approaches to health and wellness to support global health outcomes, today provided a transparency update regarding its Equity Line of Credit (ELOC) agreem...
2025-08-01 00:45
5687
Neurophet Showcases Full-Cycle Brain Imaging Analysis Solutions for Alzheimer's disease Including 'Neurophet AQUA AD' at AAIC 2025
* Showcased brain imaging analysis products such as Neurophet AQUA AD, capable of monitoring side effects of Alzheimer's disease treatments * Engaged in partnering with global big pharma and neurology KOLs, seeking global development collaborations for key products SEOUL, South Korea, July 31,...
2025-07-31 21:00
2842
Pop Culture Group's Investment Project "Huaya Times" Officially Launches in Xiamen
XIAMEN, China, July 31, 2025 /PRNewswire/ -- Huaya Times (华雅•时代), a project invested by Pop Culture Group Co., Ltd. (Nasdaq: CPOP), officially launched on July 24, 2025. The project introduces a new residential product, "Huaya Times," by Budian Home, presenting a groundbreaking solution for the mo...
2025-07-31 20:45
3484
Chipscreen Biosciences' Brain-Penetrant Aurora B Selective Inhibitor CS231295 Tablet Receives FDA IND Approval, Advancing Global Clinical Development
SHENZHEN, China, July 31, 2025 /PRNewswire/ -- Shenzhen Chipscreen Biosciences Co., Ltd. ("Chipscreen Biosciences") announced that its wholly owned subsidiary, Chipscreen Biosciences (USA) Ltd., has received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) ...
2025-07-31 17:55
3098
Autohome Inc. Announces Unaudited Second Quarter and Interim 2025 Financial Results
BEIJING, July 31, 2025 /PRNewswire/ -- Autohome Inc. (NYSE: ATHM; HKEX: 2518) ("Autohome" or the "Company"), the leading online destination for automobile consumers inChina, today announced its unaudited financial results for the three months and six months ended June 30, 2025. Second Quarter 20...
2025-07-31 17:30
4565
TAL Education Group Announces Unaudited Financial Results for the First Fiscal Quarter Ended May 31, 2025
BEIJING, July 31, 2025 /PRNewswire/ -- TAL Education Group (NYSE: TAL) ("TAL" or the "Company"), a smart learning solutions provider inChina, today announced its unaudited financial results for the first quarter of fiscal year 2026 ended May 31, 2025. Highlights for the First Quarter of Fiscal Ye...
2025-07-31 17:00
4221
Youdao to Report Second Quarter 2025 Financial Results on August 14
HANGZHOU, China, July 31, 2025 /PRNewswire/ -- Youdao, Inc. ("Youdao" or the "Company") (NYSE: DAO), an AI-powered solutions provider specializing in artificial intelligence applications for the learning and advertising verticals, today announced that it will report its second quarter 2025 finan...
2025-07-31 16:30
2192
ZTO to Announce Second Quarter and Half-Year Interim Financial Results of 2025 on August 19, 2025 U.S. Eastern Time
SHANGHAI, July 31, 2025 /PRNewswire/ -- ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057) ("ZTO" or the "Company"), a leading and fast-growing express delivery company inChina, today announced that it will release its unaudited financial results for the second quarter endedJune 30, 2025 and it...
2025-07-31 16:30
3609
NetEase to Report Second Quarter 2025 Financial Results on August 14
HANGZHOU, China, July 31, 2025 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or the "Company"), a leading internet and game services provider, today announced that it will report financial results for the 2025 second quarter on Thursday, August 14, 2025, before the open of...
2025-07-31 16:30
2861
Tuniu to Report Second Quarter 2025 Financial Results on August 15, 2025
NANJING, China, July 31, 2025 /PRNewswire/ -- Tuniu Corporation (NASDAQ:TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company inChina, today announced that it plans to release its unaudited financial results for the second quarter endedJune 30, 2025, before the market opens on...
2025-07-31 14:00
2760
Luxshare Precision Reaffirms Commitment to Cross-Cultural Friendship and Unity Through "Luxshare Cup" Global Relay
NEW YORK, July 31, 2025 /PRNewswire/ -- On the occasion of International Friendship Day, Luxshare Precision Industry Company Limited underscores its ongoing commitment to promoting cross-cultural understanding and global solidarity. As a multinational enterprise, the company continues to foster ...
2025-07-31 13:49
3024
Amcor to report fiscal 2025 fourth quarter and full year results
ZURICH, July 30, 2025 /PRNewswire/ -- Amcor plc (NYSE: AMCR; ASX: AMC) will announce its fiscal 2025fourth quarter and full year results for the three month and twelve month period ended30 June 2025, before the US market opens on Thursday 14 August 2025. A conference call and webcast to discuss...
2025-07-31 11:56
2411
Akeso Announces Completion of First Dosing in Phase III Clinical Trial of Ivonescimab (PD-1/VEGF) Combination Therapy for Immunotherapy-Resistant NSCLC
HONG KONG, July 30, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in its pivotal Phase III clinical study (AK112-305/HARMONi-8A) of ivonescimab (PD-1/VEGF bispecific antibody) in combination with docetaxel for the treatment o...
2025-07-31 09:46
2463
Week's Top Stories
Most Reposted
DBS crowned Southeast Asia's most valuable brand in Kantar BrandZ 2026 ranking
[Picked up by 305 media titles]
2026-07-15 12:00
Visa Reimagines Visa Infinite for Asia Pacific's Modern Affluent
[Picked up by 302 media titles]
2026-07-16 10:00
Gnomey Hollows Opens at PARKROYAL COLLECTION Marina Bay, Singapore, Extending the Hotel's Gnome-Themed Family Experience
[Picked up by 290 media titles]
2026-07-13 11:42
Tetra Pak Introduces Industry-first Carton Packaging for Shelf-stable Tuna to Support Southeast Asia's Growing Tuna Industry
[Picked up by 287 media titles]
2026-07-13 10:00
Klook signs an expanded two-year partnership with Korea Tourism Organization
[Picked up by 286 media titles]
2026-07-16 17:49
Most Read
PTCL Group Leadership Meets FinVolution at MWC Shanghai 2026 to Explore Credit Technology for Financial Inclusion in Pakistan
2026-07-14 18:32
6126
[Official Launch] AGONG Durian Uses Blockchain to Authenticate Every Musang King
2026-07-13 19:53
6011
![[Official Launch] AGONG Durian Uses Blockchain to Authenticate Every Musang King](https://mma.prnasia.com/media2/3005680/image1.jpg?p=medium600)
Former INTERPOL President H.E. Ahmed Naser Al-Raisi Joins Robo.ai as Chairman of Neurovia AI to Build Trusted, Sovereign AI Infrastructure in the UAE and GCC Region
2026-07-13 13:31
5916
NYSE Content Update: Madrona Highlights Private Companies Building AI Apps
2026-07-14 21:26
5767
